Open-label, multicentre study to assess the persistence on treatment in women with postmenopausal osteoporosis receiving once-monthly ibandronic acid with either a patient support programme (PSP) or b...

Update Il y a 5 ans
Reference: ISRCTN64773345

Open-label, multicentre study to assess the persistence on treatment in women with postmenopausal osteoporosis receiving once-monthly ibandronic acid with either a patient support programme (PSP) or bone turnover marker monitoring (BM)